Evidence map›Paper›PMID 25035790›Full record

ArticleInternational journal of clinical and experimental medicine2014

A novel case report of sickle cell disease-associated immunoglobulin A nephropathy: the diagnostic value of erythrocyte dysmorphism evaluation.

Gyl Eb Silva, André C Teixeira, José Gg Vergna, Natalino Salgado-Filho, Leandro Z Crivellentti, Roberto S Costa, Márcio Dantas

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Medullary Microvascular Thrombosis and Injury in Sickle Hemoglobin C Disease.Journal of the American Society of Nephrology : JASN · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gyl Eb SilvaDepartment of Pathology, Ribeirão Preto Medical School, University of São Paulo Brazil.
André C TeixeiraDepartment of Pathology, Ribeirão Preto Medical School, University of São Paulo Brazil.
José Gg VergnaDivision of Nephrology, Ribeirão Preto Medical School, University of São Paulo Brazil.
Natalino Salgado-FilhoDivision of Nephrology, University Hospital of Federal University of Maranhão Brazil.
Leandro Z CrivellenttiDepartment of Pathology, Ribeirão Preto Medical School, University of São Paulo Brazil.
Roberto S CostaDepartment of Pathology, Ribeirão Preto Medical School, University of São Paulo Brazil.
Márcio DantasDivision of Nephrology, Ribeirão Preto Medical School, University of São Paulo Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sickle cell disease is a severe disease with a genetic pattern; it may cause anemia, vaso-occlusive phenomena, and multiorgan injury. It may damage any renal compartment, thereby causing tubular abnormalities, papillary necrosis, or glomerulopathies such as focal and segmental glomerulosclerosis and membranoproliferative pattern. The clinical consequences are hematuria and proteinuria. Hematuria associated with SCD is characteristically isomorphic (non-glomerular). This case report describes a novel case of a patient with sickle cell disease who presented with proteinuria and microscopic dysmorphic (glomerular) hematuria. A renal biopsy revealed immunoglobulin A nephropathy. Despite the fact that immunoglobulin A nephropathy is the most commonly diagnosed glomerulonephritis worldwide, an association between this entity and sickle cell disease has not yet been reported, probably because all cases of hematuria in patients with sickle cell disease have been regarded as secondary to sickle cell disease. Thus, new approaches are necessary to differentiate these conditions, such as evaluation of urinary erythrocyte dysmorphism, even more so because these two entities have different therapeutic options, morbidity, and mortality rates.

Indexed as

erythrocyte dymorphismglomerulonephritisIgA nephropathysickle cell disease

Identifiers

PMID25035790
PMCPMC4100976
OpenAlexW2309538124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.